Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific CSNK1A1 CK1, CK1a, CK1alpha, CKIa, CKIalpha ENSG00000113712 Casein kinase 1, alpha 1 5 149492197-149551552 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB016680, HPA051334 Uncertain Approved Cytosol Colorectal cancer:1.15e-4 (favourable), Pancreatic cancer:5.79e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 230.2 CSNK1A1L MGC33182 ENSG00000180138 Casein kinase 1, alpha 1-like 13 37103259-37105664 Enzymes, Predicted intracellular proteins Evidence at transcript level HPA051334 Uncertain Cytosol Not detected Tissue enriched 16 testis: 6.4 bone marrow: 0.3 CSNK1D CKID, CKIdelta, HCKID ENSG00000141551 Casein kinase 1, delta 17 82239023-82273731 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level CAB015410 Approved Supported Nucleus
Nucleoli fibrillar center Liver cancer:2.38e-6 (unfavourable), Pancreatic cancer:9.62e-5 (favourable), Endometrial cancer:7.04e-4 (unfavourable), Renal cancer:8.34e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 67.1 CSNK1E CKIE, CKIepsilon, HCKIE ENSG00000213923 Casein kinase 1, epsilon 22 38290691-38398522 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level CAB009626, HPA026288 Approved Approved Nucleus
Cytosol Renal cancer:4.67e-6 (unfavourable), Liver cancer:8.20e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 173.6 CSNK1G1 CK1gamma1 ENSG00000169118 Casein kinase 1, gamma 1 15 64165517-64356259 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA018209 Supported Cytosol Expressed in all Tissue enhanced testis: 63.5 thyroid gland: 14.1 CSNK1G2 CK1g2 ENSG00000133275 Casein kinase 1, gamma 2 19 1941149-1981338 Enzymes, Predicted intracellular proteins Evidence at protein level HPA034868, HPA056572 Uncertain Approved Vesicles Expressed in all Expressed in all testis: 77.2 CSNK1G3 ENSG00000151292 Casein kinase 1, gamma 3 5 123512099-123617045 Enzymes, Predicted intracellular proteins Evidence at protein level HPA027010 Approved Colorectal cancer:9.90e-5 (favourable) Expressed in all Expressed in all testis: 28.2 TTBK1 KIAA1855 ENSG00000146216 Tau tubulin kinase 1 6 43243680-43288259 Enzymes, Predicted intracellular proteins Evidence at protein level HPA031735, HPA031736 Supported Supported Nucleoplasm
Cytosol Tissue enhanced Tissue enriched 6 cerebral cortex: 19.0 small intestine: 3.2 TTBK2 KIAA0847, SCA11 ENSG00000128881 Tau tubulin kinase 2 15 42738734-42920809 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA018113, HPA049866 Approved Uncertain Intermediate filaments Mixed Tissue enhanced testis: 60.7 cerebral cortex: 16.7 VRK1 ENSG00000100749 Vaccinia related kinase 1 14 96797304-96931722 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA000660, HPA017929 Approved Supported Nucleus
Cytosol Liver cancer:4.15e-4 (unfavourable) Expressed in all Mixed testis: 59.5 VRK2 ENSG00000028116 Vaccinia related kinase 2 2 57907651-58159920 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB046459, HPA047503 Approved Supported Endoplasmic reticulum Liver cancer:6.32e-6 (unfavourable), Renal cancer:4.66e-5 (unfavourable), Pancreatic cancer:4.65e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 29.2 VRK3 ENSG00000105053 Vaccinia related kinase 3 19 49976467-50025946 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA056489 Approved Supported Nucleus
Vesicles Renal cancer:1.83e-4 (favourable), Urothelial cancer:5.66e-4 (favourable) Expressed in all Expressed in all testis: 168.2